Pharmaleaders TV
You are here:  / Meetings / Profiles / Trending / World news / Artificial Heart Surgeon Dr Mukesh Hariawala to be honoured India’s Most Admired Surgeon

Artificial Heart Surgeon Dr Mukesh Hariawala to be honoured India’s Most Admired Surgeon


Pioneering Angiogenesis Indian Born Boston based NRI Surgeon who shot to fame for his cutting edge innovations Titanium VAD (Ventricular Assist Devices), to floor the audience via Keynote at 5th Annual Pharmaceutical Leadership Summit 2012

July 31, 2012 5:38 pm – Maharashtra, Mumbai, Tuesday 31st July 2012. Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( ) is all set to buzz in Mumbai on 21st Sept on a title track Brand India, organized by Asia’s most analytical Healthcare bi-monthly magazine Pharmaleaders ( ) in association with the Ministry of Commerce & industries, Government of India , Pharmexcil (Pharmaceuticals Export Promotion Council Of India, Set up by Ministry of Commerce & Industry, Govt of India) & several other pressure groups & trade organizations. The Annual Affair will bring some of the finest brains of the world in a single platform says Satya Brahma, Editor-In-Chief of Pharmaleaders Magazine, “Pharmaleaders’s Focus is to sensitize & pressurize the Government on key reforms that has been pending for years, advise the healthcareproviders to provide quality medicines at affordable rates & bring uncomfortable topics that are generally not debated in any top platforms”. This is the platform that will give rise to some of the biggest issues the industry is confronting.

The Coveted Title for this year’s selection India’s Most Admired Surgeon 2012 was unanimous both by the Indian surgical community as well as the Jury Members consisting of 5 member body having cross section representation from the Indian Government, Indian Healthcare Sector, Consultants & journalists. And it is Harvard University trained, internationally acclaimed Cardiac Surgeon and Healthcare Economist Dr Mukesh Hariawala. This choice would hardly be a surprise to the healthcare professionals who have followed his 25 year 3 continent glittering career journey. The recognition is truly global & is spectacular considering the high importance of this category. The previous recipient of this Award was veteran Dr. Ramakanta Panda who is one of India’s leading cardiac surgeons, and the Vice Chairman and Managing Director of the Asian Heart Institute. Dr Panda is a globally-reputed cardiac surgeon with impeccable credentials, who operated on Dr. Manmohan Singh, the Prime Minister of India. This successful ‘redo bypass’, the second for Dr. Singh, further cemented Dr. Panda’s reputation as one of India’s leading cardiac surgeons.

Announcing the name of Dr Mukesh Hariawala as the proud recipient of such an honour , Satya Brahma, Chairman of the 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 who also spoke to the Boston based Doctor in US said “ Dr Mukesh symbolizes innovations in best practices & is very down –to-earth, someone who has spent nearly two & half decades inhealthcare practice & has catapulted to the limelight after he operated the first Surgery to the present Indian Prime Minister, Dr Manmohan Singh. The great co-incidence is that while the previcious recipient Dr Panda was the latest one to operate, the first operation was done by Dr Mukesh Hariawala”. “Dr Mukesh Hariawala is reputed to be one of the safest heart surgeons in the world, with a 99.5% success rate in bypass surgery” added Satya in a News Release. Dr Mukesh Hariawala is scheduled to fly from US to India to deliver his Keynote Address on Are We Ready For A ” Mechanical Artificial Heart ” For Indian Patients. An overview & will also receive the Award on 21st Friday, September in a suburban Mumbai Hotel, India.

It may be noted here that Dr Hariawala has done pioneering research work in the field of Cardiac Angiogenesis which is the spontaneous development of new blood vessels in the heart by laser stimulation and subsequent injection of patients own Stem Cells harvested from bone marrow. This unique “Triple Heart Therapy ” would be the future treatment of heart disease which is expected to save millions of lives worldwide. The low cost procedure would be a major expense containment particularly for the under privileged indian patients with diabetes who cannot afford expensive operations. It is a natural bypass to bypass surgery, explains Dr Hariawala. “I want to see a vibrant and aggressive government policy where India’s monetary resources are better utilized towards rural development and raising the standards of living for all Indians, asserted Boston based Dr Hariawala who also recently became one of the first cardiac surgeons in the world to qualify with an Executive Healthcare MBA added Dr Hariawala.

The award is to be presented to him in a power packed veterans of the Healthcare Industry by His Excellency Maharashtra Governor Shri K. Sankaranarayanan in the presence of who’s & who’s of Healthcare Exprts in India with several representation from overseas countries and several invited dignitaries from a cross section of all industries.Dr Hariawala who is the only NRI surgeon to hold a special Honorary Visiting Cardiac Surgeon appointment at Mumbai’s Jaslok Hospital . He will also deliver the ” Keynote Lecture ” on cutting edge technology ” Mechanical Artificial Heart ” which he plans to bring to India next year. This Titanium Heart is an alternative to Transplantation which is Lithium ion battery powered. This will bring a big relief to heart patients who are normally bedridden who have no options and do not qualify medically as candidates for procedures like Angioplasty , Stents or Bypass Surgery.” Dr Hariawala is expected to wrap up his keynote with critical analysis of the 100 Billion Dollar Medical Tourism opportunity as projected by accounting giants Deloitte and Company. US president Barack Obama’s Healthcare Reform Bill details will be presented and its impact on India’s strategic planning into this opportunity. ” Socialization of US Healthcare System is India’s next biggest opportunity after the Software industry boom ” says an optimistic Dr Hariawala.

Dr Hariawala’s celebrity patients include Prime Minister Dr Manmohan Singh , Music maestro R D Burman , BCCi Chairman Raj Singh Dungarpur , Industrialist Ramkrishna Bajaj , Goenka and many more. He has also delivered keynote lectures as Chairman of Cardiac Surgery at the recently concluded World Congress of Cardiology in Dubai and is booked to speak in Beijing, China at the Olympic Arena to commemorate the annual Great Wall Cardiology conference in October ‘ 2012. The medical world often finds itself clueless when it comes to providing treatment to the patients with terminal heart disease who are not candidates for routine angioplasty, stent or bypass surgery. Such patients can benefit only by transplantation which is not a practical solution due to severe shortage of donor hearts. However, here is good news for these patients in India: Titanium VAD (Ventricular Assist Devices), which functions as an “Artificial Heart,” can give them a new life, says acclaimed cardiac surgeon Dr. Mukesh Hariawala.

For more information, visit:


Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.


Your email address will not be published. Required fields are marked ( required )

This site uses Akismet to reduce spam. Learn how your comment data is processed.

July 2019
« Apr    
Follow us
Contact us

Network 7 Meadia Group

Plot 5, NS Road No. 12, JVPD, Juhu Scheme, Mumbai, Maharashtra 400049.